Early Serum Infliximab Levels in Severe Ulcerative Colitis
Phase of Trial: Phase I
Latest Information Update: 09 Jun 2015
Price : $35 *
At a glance
- Drugs Infliximab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms EaSiFx
- 31 Aug 2018 Biomarkers information updated
- 26 May 2015 Status changed from recruiting to completed according to ClinicalTrials.gov record.
- 03 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.